Literature DB >> 1586609

Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer.

D M Hemingway1, T G Cooke, G McCurrach, R G Bessent, R Carter, J H McKillop, C S McArdle.   

Abstract

The hepatic perfusion index, the ratio of hepatic arterial to total liver blood flow, was measured in 50 consecutive patients with colorectal cancer using radiolabelled colloid with high administered activity. In patients with proven liver metastases the diagnostic sensitivity of the HPI was 96% and the predictive value of a negative test was 92%. Dynamic hepatic scintigraphy is of value in the management of patients with colorectal cancer.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1586609      PMCID： PMC1977371          DOI： 10.1038/bjc.1992.166

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  8 in total

1.  Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease.

Authors:  J A Goldberg; J Fenner; R G Bessent; M S Bradnam; J H McKillop; R F McKee; C S McArdle; D J Kerr
Journal:  Nucl Med Commun       Date:  1989-08       Impact factor: 1.690

2.  The blood supply of neoplasms in the liver.

Authors:  C BREEDIS; G YOUNG
Journal:  Am J Pathol       Date:  1954 Sep-Oct       Impact factor: 4.307

3.  Reliability of the hepatic perfusion index for the detection of liver metastases.

Authors:  A C Perkins; D R Whalley; K C Ballantyne; J D Hardcastle
Journal:  Nucl Med Commun       Date:  1987-12       Impact factor: 1.690

4.  Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats.

Authors:  D M Hemingway; T G Cooke; S J Grime; D M Nott; S A Jenkins
Journal:  Br J Surg       Date:  1991-03       Impact factor: 6.939

5.  Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer.

Authors:  K C Ballantyne; R M Charnley; A C Perkins; G Pye; D R Whalley; M L Wastie; J D Hardcastle
Journal:  Nucl Med Commun       Date:  1990-01       Impact factor: 1.690

6.  Dynamic hepatic scintigraphy: the effect of using high administered activity on reproducibility of hepatic perfusion index value.

Authors:  D M Hemingway; G McCurrach; R G Bessent; J H McKillop; T G Cooke
Journal:  Nucl Med Commun       Date:  1991-09       Impact factor: 1.690

7.  Hepatic perfusion index in cirrhotic livers--investigation of imaging and analytical procedures.

Authors:  B Leng; M P O'Driscoll; F A Majeed; J S Grime; M Critchley
Journal:  Nucl Med Commun       Date:  1987-12       Impact factor: 1.690

8.  A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.

Authors:  I Taylor; D Machin; M Mullee; G Trotter; T Cooke; C West
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939
  8 in total
  4 in total

1.  A prospective study of six methods for detection of hepatic colorectal metastases.

Authors:  R Carter; D Hemingway; T G Cooke; R Pickard; F W Poon; J A McKillop; C S McArdle
Journal:  Ann R Coll Surg Engl       Date:  1996-01       Impact factor: 1.891

2.  Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver?

Authors:  Y Tsushima; M J Blomley; H Yokoyama; S Kusano; K Endo
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

Review 3.  Colorectal liver metastases.

Authors:  D Burke; T G Allen-Mersh
Journal:  Postgrad Med J       Date:  1996-08       Impact factor: 2.401

Review 4.  Hepatic arterial chemotherapy for metastatic colorectal carcinoma.

Authors:  P G de Takats; D J Kerr; C J Poole; H W Warren; C S McArdle
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.